期刊文献+

药物洗脱支架置入与冠状动脉搭桥治疗糖尿病患者冠状动脉多支病变近中期疗效的比较 被引量:1

Comparation drug eluting stents and coronary artery bypass graft in diabetes patients with multivessel coronary artery disease
原文传递
导出
摘要 目的:比较雷帕霉素洗脱支架(DES)置入术与冠状动脉搭桥术(CABG)治疗糖尿病并发冠状动脉多支病变患者的近中期疗效。方法:回顾性分析2003-07-01-2004-06-30入院并接受DES置入或CABG治疗的糖尿病患者490例的基础临床资料、院内及院外随访资料,比较不同冠状动脉血运重建方式对糖尿病多支病变患者临床结果的影响。结果:250例患者接受DES置入(DES组),240例患者选择CABG治疗(CABG组)。与DES组相比,CABG组患者的冠状动脉病变更为复杂,左主干病变以及慢性闭塞病变的比例较高;DES组弥漫长病变以及再狭窄病变的比例较高。CABG组与DES组院内不良心脑血管事件(MACCE)发生率差异无统计学意义(3.3%∶1.2%,P>0.05)。共有440例患者接受了不同形式的随访,随访率为89.7%。2组患者随访病死率、非致死性脑卒中以及非致死性心肌梗死的发生率均差异无统计学意义;但DES组患者需要再次血运重建的比例明显高于CABG组(11.3%∶1.9%,P<0.01);DES组患者随访MACCE发生率高于CABG组(17.4%∶8.6%,P<0.01)。再次血运重建比例较高是导致DES组随访不良事件增加的主要原因。结论:糖尿病多支病变患者CABG后近中期MACCE发生率低于DES置入术。 Objective:To compare the clinical outcomes of contemporary revascularization technique in diabetes with multivessel coronary artery disease(MVD) and evaluate the effectiveness of drug eluting stent in "real world" clinical practice. Method: A total of 490 diabetes patients with MVD revascularied with PCI or CABG from July 1, 2003 to June 30, 2004 were recruited. All patient's clinical manifestations, inhospital revascularization characteristics and follow up results were analyzed retrospectively. Resuit:PCI was performed and DES was implanted in 250 patients (DES group). CABG were performed in 240 patients (CABG group). Compared with DES group, coronary lesions characteristic in CABG group were more complex, the proportion of left main disease and chronic total occlusion were higher than that of in DES group. The proportion of diffuse long lesions and instent restenosis in DES group were higher than that in CABG group. The main adverse cardio-cerebral events (all casused death, non-fatal myocardial infarction, non-fatal stroke and repeat revascularization) inhospital were similar between two group (3.3% vs 1.2% ,P〉0.05), 440 patients completed clinical follow up, during the period of follow up, there were not statistical difference in mortality and non-fatal myocardial infarction between two groups, The rate of main adverse cardio-cerebral events in DES group was a higher than that of in CABG group(17.4% vs 8.6% ,P〈0.01). mainly because of an increased repeat revascularization in DES group (11.3% vs 1.9%, P〈0.01). Conclusion: The rate of main adverse cardio-cerebral events in patients with MVD was lower in CABG group even in the era of drug eluting stents.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2009年第5期327-330,共4页 Journal of Clinical Cardiology
基金 国家重点基础研究发展规划项目(973计划)资金资助(No:2003CB517103)
关键词 血管成形术 经腔 经皮冠状动脉 心血管疾病 外科手术 糖尿病 冠状动脉疾病 angioplasty, transluminal, percutaneous coronary angiocardiopathy , surgery diabetes coronary disease
  • 相关文献

参考文献15

  • 1SABATE M, JIME NEZ-QUEVEDO P, ANGIOLILLO D J, et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial[J]. Circulation, 2005,112 : 2175- 2183.
  • 2DIBRA A, KASTRATI A, MEHILLI J, et al. Paclitaxel-eluting or sirolimus eluting stents to prevent restenosis in diabetic patients [J]. N Engl J Med, 2005,353 : 663-670.
  • 3DEGERTEKIN M, ARAMPATZIS C A, LEMOS P A, et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions[J]. Am J Cardiol, 2004, 93:826-829.
  • 4CARSON J L, SCHOLZ P M, CHEN A Y, et al. Diabetes mellitus increases shortterm mortality and morbidity in patients undergoing coronary artery bypass graft surgery[J]. J Am Coll Cardiol, 2002,40: 418-423.
  • 5YANG J H,GWON H C,CHO S J,et al. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of muttivessel coronary artery disease[J]. Ann Thorac Surg ,2008, 85:65-70.
  • 6MERCADO N, WIJNS W, SERRUYS P W, et al. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials [J]. J Thorac Cardiovasc Surg, 2005, 130:512-519.
  • 7HAFFNER S M, LEHTO S, RONNEMAA T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction[J]. N Engl J Med, 1998,339 : 229-234.
  • 8WOODFIELD S L, LUNDERGAN C F, REINER J S, et al. GUSTO-I Angiographic Investigators. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-1 experience[J]. J Am Coll Cardiol, 1996, 28:1661-1669.
  • 9GOMES R S. Percutaneous coronary intervention with drug eluting stents for diabetic patients [J]. Heart, 2006,92:410-419.
  • 10The BARI investigators. Influence of diabetes on 5- year mortality and morbidity in a randomized trial comparing pTCA and CABG in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) [J]. Circulation ,1997, 96:1761-1769.

同被引文献30

  • 1王燕燕,王晓,邵加庆,赵明,汤沂.2型糖尿病患者冠状动脉病变的特点[J].江苏医药,2005,31(3):219-220. 被引量:3
  • 2Naik H, White AJ, Chakravarty T, et al. A meta - analysis of 3, 773 patients treated with pereutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis [ J ]. JACC Cardiovasc Interv, 2009, 2 (8): 739-747.
  • 3Chieffo A, Magni V, Latib A, et al. 5 -year outcomes following percutaneous coronary intervention with drug eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience [ J ]. JACC Cardiovasc Interv, 2010, 3 (6): 595-601.
  • 4Dimopoulos K, Dudek D, Piscione F, et al. Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: implications on optimisation of timing of treatment from the CARESS-in -AMI trial [J]. Int J Cardiol, 2012, 154 (3): 275 - 281.
  • 5Kim YH, Park DW, Kim WJ, et al. Impact of the extent of coronary artery disease on outcomes after revascularization for unprotected left main coronary artery stenosis : J ]. J Am Coll Cardiol, 2010, 55 (23): 2544-2552.
  • 6Montalescot G, Brieger D, Eagle KA, et al. Unprotected left main revascularization in patients with acute coronary syndromes [ J ]. J Eur Heart, 2009, 30 (19): 2308-2317.
  • 7Lindvall B, Brorsson B, Herlirz J, et al. Compatison of diabetes and non - diabetic patients referred for coronary angiography [ J J. Internatonal Journal of Cardiology, 1999, 70 (1) : 33 -42.
  • 8Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [ J ]. N Eng J Med, 1998, 339 (4): 229-234.
  • 9Woodfield SL, Lundergan CF, Reiner JS, et al. GUSTO - I Angiographic Investigators. AngiogTaphic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction : the GUSTO - 1 experience [ J ]. J Am Coll Cardiol, 1996 (28): 1661-1669.
  • 10Gomes RS. Percutaneous coronary intervention with drug eluting stents for diabetic patients [J:. Heart, 2006 (92) : 410 -419.

引证文献1

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部